Literature DB >> 23784726

Can the Ordered Multi-Stepping Over Hoop test be useful for predicting fallers among older people? A preliminary 1 year cohort study.

Kota Tsutsumimoto1, Takehiko Doi, Shogo Misu, Rei Ono, Soichiro Hirata.   

Abstract

BACKGROUND AND AIMS: To prevent falls among older people, we developed a new fall-risk assessment, the "Ordered Multi-Stepping Over Hoop (OMO)" test. The aims of this study were preliminary: to investigate the association of the OMO with cognitive and physical function and to investigate whether the OMO could predict incidents of falling.
METHODS: Fifty-nine community-dwelling older people (mean age = 88.0 ± 0.87, female = 49) were recruited. We assessed cognitive and physical function including the OMO test at baseline and monitored the falls of participants during a 12-month follow-up period from the baseline. We investigated whether the OMO was associated with cognitive function, physical function, and incidents of falling. To investigate whether the OMO could predict incidents of falling, a receiver operating characteristic analysis was conducted.
RESULTS: The OMO time in fallers was significantly slower than for non-fallers. There were significant correlations between slower OMO times and lower physical functions and executive function. The area under the ROC curve in the OMO was 0.71 (p < 0.05). Times above 21.9 s for the OMO identified those more likely to fall.
CONCLUSIONS: The OMO time was correlated with cognitive function, physical function, and incidents of falling. Our preliminary study indicates that the OMO may help to make a distinction between fallers and non-fallers among older people as effectively as other tests.

Entities:  

Mesh:

Year:  2013        PMID: 23784726     DOI: 10.1007/s40520-013-0061-6

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  1 in total

1.  Practical and validated tool to assess falls risk in the primary care setting: a systematic review.

Authors:  Wytske Ma Meekes; Joke C Korevaar; Chantal J Leemrijse; Ien Am van de Goor
Journal:  BMJ Open       Date:  2021-09-29       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.